These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
477 related items for PubMed ID: 15233705
1. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Delvaux M, Beck A, Jacob J, Bouzamondo H, Weber FT, Frexinos J. Aliment Pharmacol Ther; 2004 Jul 15; 20(2):237-46. PubMed ID: 15233705 [Abstract] [Full Text] [Related]
2. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, Urso D. Aliment Pharmacol Ther; 2008 Jul 15; 28(2):239-49. PubMed ID: 18466359 [Abstract] [Full Text] [Related]
3. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, Zinsmeister AR. Am J Physiol Gastrointest Liver Physiol; 2003 Apr 15; 284(4):G558-66. PubMed ID: 12631557 [Abstract] [Full Text] [Related]
4. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Floyd BN, Camilleri M, Busciglio I, Sweetser S, Burton D, Wong GY, Kell S, Khanna S, Hwang S, Zinsmeister AR. Neurogastroenterol Motil; 2009 Mar 15; 21(3):281-90. PubMed ID: 18823290 [Abstract] [Full Text] [Related]
5. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome. Ng C, Malcolm A, Hansen R, Kellow JE. Neurogastroenterol Motil; 2006 Mar 15; 18(3):206-10. PubMed ID: 16487411 [Abstract] [Full Text] [Related]
6. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Aliment Pharmacol Ther; 1998 Sep 15; 12(9):849-55. PubMed ID: 9768527 [Abstract] [Full Text] [Related]
14. Asimadoline in the treatment of irritable bowel syndrome. Mangel AW, Williams VS. Expert Opin Investig Drugs; 2010 Oct 15; 19(10):1257-64. PubMed ID: 20809870 [Abstract] [Full Text] [Related]
15. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L. Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995 [Abstract] [Full Text] [Related]
16. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR. Gastroenterology; 2007 Sep 15; 133(3):761-8. PubMed ID: 17854590 [Abstract] [Full Text] [Related]
17. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Am J Physiol Gastrointest Liver Physiol; 2007 Jul 15; 293(1):G137-45. PubMed ID: 17395895 [Abstract] [Full Text] [Related]
18. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis. Binder W, Walker JS. Br J Pharmacol; 1998 Jun 15; 124(4):647-54. PubMed ID: 9690855 [Abstract] [Full Text] [Related]